Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46.5Revenue (TTM) $M0.2Net Margin (%)-32,700.0Altman Z-Score-10.8
Enterprise Value $M11.3EPS (TTM) $-0.9Operating Margin %-32,507.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.6Pre-tax Margin (%)-32,699.5Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %-7.8Quick Ratio3.1Cash flow > EarningsY
Price/Sales1435-y EBITDA Growth Rate %-3.0Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-95.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-173.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M109ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CYTR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CYTR is held by these investors:



CYTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patterson Scott Bradford10% Owner 2013-12-03Buy284,979$2.44-82.38view
Patterson Scott Bradford10% Owner 2013-11-07Buy50,000$2.06-79.13view
Patterson Scott Bradford10% Owner 2013-04-01Buy4,083$2.7-84.07view
Patterson Scott Bradford10% Owner 2013-03-20Buy35,520$2.58-83.33view
Patterson Scott Bradford10% Owner 2013-03-20Buy3,980$2.61-83.52view
Patterson Scott Bradford10% Owner 2013-03-13Buy55,360$2.67-83.9view
Patterson Scott Bradford10% Owner 2012-10-22Buy180,000$2.51-82.87view
Patterson Scott Bradford10% Owner 2012-10-18Buy1,200,000$2.5-82.8view
Patterson Scott Bradford10% Owner 2012-06-28Buy44,824$5.14-91.63view
Patterson Scott Bradford10% Owner 2012-06-25Buy27,462$5-91.4view

Quarterly/Annual Reports about CYTR:

News about CYTR:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
Weekly CEO Buys Highlight: ULBI, BDE, ALNY, CTTR, GFN Feb 27 2012 
Weekly CFO Buys Highlight: CYTR, PZZI, AGYS, PLBC Feb 27 2012 
CytRx Corp. Reports Operating Results (10-K) Mar 11 2011 
CytRx Corp. Reports Operating Results (10-Q) Nov 08 2010 
CytRx Corp. Reports Operating Results (10-Q) Aug 09 2010 
CytRx Corp. Reports Operating Results (10-Q) May 06 2010 
CytRx Corp. Reports Operating Results (10-Q) Nov 09 2009 
CytRx Corp. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
CYTRX CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or... Feb 24 2017
CytRx to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 13 2017
CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 06 2017
CytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a... Jan 04 2017
CytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a... Jan 04 2017
Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock? Dec 30 2016
CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 19 2016
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer Dec 19 2016
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer Dec 19 2016
CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of... Dec 14 2016
How CytRx Corporation (CYTR) Stacks Up Against Its Peers Dec 14 2016
CytRx Corporation Announces $8.1 Million Registered Direct Offering of Common Stock Dec 13 2016
CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 02 2016
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board of Directors Dec 02 2016
CytRx CEO Pockets Millions of Dollars as Failed Sarcoma Drug Moves to FDA Nov 29 2016
CytRx Reports Statistically Significant Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin... Nov 29 2016
CYTRX CORP Files SEC form 8-K, Regulation FD Disclosure Nov 29 2016
CYTRX CORP Financials Nov 17 2016
CytRx Gets a Second Look (CYTR) Nov 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)